建業地產(00832.HK)發行4億美元優先票據
格隆匯6月9日丨建業地產(00832.HK)發佈公告,2020年6月8日,公司、附屬公司擔保人及附屬公司擔保出質人與法國巴黎銀行、美銀證券、花旗、中信銀行(國際)、瑞信、海通國際、摩根士丹利及渣打銀行就發行4億美元2023年到期票息7.65%優先票據訂立購買協議。
票據將依據美國證券法S規例在美國境外提呈發售。公司擬運用於扣除佣金及其他費用後所得款項淨額作償還其將於一年內到期現有中長期境外債項之用。公司或會因應市況變動調整其計劃,並因而重新分配票據發行所得款項用途。
新加坡證券交易所已原則上批准票據於新加坡證券交易所上市及於正式上市名單報價。公司並未尋求票據在香港上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.